Archive (english)

This is a translation of the table of contents. One article of each issue is translated and freely available.

table of contents

SPOT ON

Bevacizumab (AVASTIN) against cancer … with money-back guarantee for hospitals

NEW ON THE MARKET

Xylometazoline + ipratropium bromide (OTRIVEN DUO) against rhinitis

Attention-deficit hyperactivity disorder: methylphenidate for adults?

a-t READER'S QUESTIONS AND COMMENTS

Reducing lipoprotein(a) with nicotinic acid?

THERAPY FROM A CRITICAL VIEWPOINT

Early benefit assessment of ticagrelor (BRILIQUE) by IQWiG

"Individual health services" (IGeL) reviewed … screening for glaucoma, ovarian and endometrial cancer without proven benefit

IN BRIEF

Cave: hyperkalemia with spironolactone plus trimethoprim

Marketing via "market research"

CURRENT ADR NETWORK REPORT

Breast cancer with glatiramer acetate (COPAXONE)

SIDE EFFECTS

Dronedarone (MULTAQ): restriction of indication and warnings instead of market withdrawal
free

e a-t IN THE INTERNET

Cardiovascular risks of varenicline (CHAMPIX)

Independent drug information – in English

Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

Browse free articles